Alessandra Fabi - Concepedia

Author

Alessandra Fabi

National Cancer Institute ORCID

Also Known As

A Fabi, A. Fabi, A. J. Fabi, A. Pace, A., Fabi, ALESSANDRA FABI, Alessandra Fabi, Andrea Pace, E. Ciruelos, Fabi

568

Publications

8.1K

Citations

H-Index

124

Concepts

All Affiliations

National Cancer Institute Istituti di Ricovero e Cura a Carattere Scientifico Sapienza University of Rome Fondazione IRCCS Istituto Nazionale dei Tumori Instituto Nazionale Tumori Regina Elena

About

Alessandra Fabi is an author at National Cancer Institute specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	72	2.9K
2	Health Sciences	11	12	806
3	Engineering	2	2	80
4	Natural Sciences	2	2	33
5	Public Health	2	2	30

Alessandra Fabi

149

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment Alessandra Fabi, Ravi Bhargava, Sonia Fatigoni, Annals of Oncology Fatigue ManagementOncologyCancer ManagementCancer-related FatigueMedicine	2020	505
CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Xavier Pivot, Alexey Manikhas, Zurawski Bogdan, Journal of Clinical Oncology	2015	248
Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine Giulio Metro, Jennifer Foglietta, Michelangelo Russillo, Annals of Oncology Neuro-oncologyBreast OncologyBrain MetastasesMedicineCancer Management	2010	167
Randomized Trial of Intravenous Iron Supplementation in Patients With Chemotherapy-Related Anemia Without Iron Deficiency Treated With Darbepoetin Alfa Paolo Pedrazzoli, A. Farris, Salvatore Del Prete, Journal of Clinical Oncology	2008	167
Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy Matti Aapro, Alessandra Fabi, Franco Nolè, Annals of Oncology	2010	147
Zoledronic-Acid-Induced Circulating Level Modifications of Angiogenic Factors, Metalloproteinases and Proinflammatory Cytokines in Metastatic Breast Cancer Patients G. Ferretti, Alessandra Fabi, Paolo Carlini, Oncology	2005	132
Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer Gabriele Minuti, Federico Cappuzzo, Renata Duchnowska, British Journal of Cancer	2012	119
Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center Alessandra Fabi, Alessandra Felici, Giulio Metro, Journal of Experimental & Clinical Cancer Research	2011	118
The course of cancer related fatigue up to ten years in early breast cancer patients: What impact in clinical practice? Alessandra Fabi, Chiara Falcicchio, Diana Giannarelli, The Breast	2017	109
A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study Flavia Novelli, Michele Stanislaw Milella, Elisa Melucci, Breast Cancer Research	2008	104

Page 1